1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Illumina, Inc.
  6. News
  7. Summary
    ILMN   US4523271090

ILLUMINA, INC.

(ILMN)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
208.33 USD   -8.40%
08/12US Stocks Climb as Inflation Expectations Wane
MT
08/12US Stocks Climb as Inflation Expectations Wane
MT
08/12Illumina, ResMed fall; Broadridge, Humana rise
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Illumina Says CFO Sam Samad to Depart July 8

06/09/2022 | 02:37pm EDT

By Stephen Nakrosis


Illumina Inc. on Thursday said Chief Financial Officer Sam Samad will depart on July 8.

Mr. Samad has been CFO for more than 5 years, Illumina said.

Joydeep Goswami, chief strategy and corporate development officer, will also serve as interim CFO as Illumina searches for a permanent CFO. Mr. Goswami was previously at Thermo Fisher Scientific and McKinsey & Co., Illumina said.


Write to Stephen Nakrosis at stephen.nakrosis@wsj.com


(END) Dow Jones Newswires

06-09-22 1637ET

Stocks mentioned in the article
ChangeLast1st jan.
ILLUMINA, INC. -8.40% 208.325 Delayed Quote.-45.24%
THERMO FISHER SCIENTIFIC 1.80% 603.21 Delayed Quote.-9.60%
All news about ILLUMINA, INC.
08/12US Stocks Climb as Inflation Expectations Wane
MT
08/12US Stocks Climb as Inflation Expectations Wane
MT
08/12Illumina, ResMed fall; Broadridge, Humana rise
AQ
08/12Morgan Stanley Lowers Price Target for Illumina to $240 From $350, Maintains Equalweigh..
MT
08/12Top Midday Decliners
MT
08/12Illumina's Shares Plunge After Lower Q2 Earnings, Price Target Cuts
MT
08/12MIDDAY REPORT : US Stocks Rise as Year-Ahead Inflation Expectations Decline
MT
08/12BofA Securities Adjusts Illumina Price Target to $200 From $220, Maintains Neutral Rati..
MT
08/12Evercore ISI Adjusts Illumina Price Target to $170 From $180, Maintains In Line Rating
MT
08/12Piper Sandler Adjusts Price Target for Illumina to $320 From $360, Maintains Overweight..
MT
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Financials (USD)
Sales 2022 4 742 M - -
Net income 2022 -475 M - -
Net cash 2022 337 M - -
P/E ratio 2022 -97,5x
Yield 2022 -
Capitalization 32 728 M 32 728 M -
EV / Sales 2022 6,83x
EV / Sales 2023 5,64x
Nbr of Employees 9 825
Free-Float 79,5%
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 208,33 $
Average target price 258,53 $
Spread / Average Target 24,1%
EPS Revisions
Managers and Directors
Francis A. deSouza President, Chief Executive Officer & Director
Joydeep Goswami Chief Financial & Strategy Officer
John Wendell Thompson Chairman
Phillip G. Febbo Chief Medical Officer
Alex Aravanis CTO, Head-Research & Product Development
Sector and Competitors
1st jan.Capi. (M$)
ILLUMINA, INC.-45.24%32 728
THERMO FISHER SCIENTIFIC-9.60%236 331
DANAHER CORPORATION-9.50%216 597
INTUITIVE SURGICAL, INC.-33.66%85 125
EDWARDS LIFESCIENCES CORPORATION-19.10%64 970
BOSTON SCIENTIFIC CORPORATION-0.35%60 600